ADAM17 inhibition may exert a protective effect on COVID-19

dc.contributor.author	Palau González, Vanesa
dc.contributor.author	Riera, Marta
dc.contributor.author	Soler, María José
dc.date.accessioned	2021-10-26T05:58:25Z
dc.date.available	2021-10-26T05:58:25Z
dc.date.issued	2020
dc.identifier.citation	Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093
dc.identifier.issn	0931-0509
dc.identifier.uri	http://hdl.handle.net/10230/48810
dc.format.mimetype	application/pdf
dc.language.iso	eng
dc.publisher	Oxford University Press
dc.relation.ispartof	Nephrol Dial Transplant. 2020;35(6):1071-2
dc.rights	© Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology, dialysis, transplantation following peer review. The version of record Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093 is available online at: http://dx.doi.org/10.1093/ndt/gfaa093
dc.title	ADAM17 inhibition may exert a protective effect on COVID-19
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	http://dx.doi.org/10.1093/ndt/gfaa093
dc.subject.keyword	covid-19
dc.rights.accessRights	info:eu-repo/semantics/openAccess
dc.type.version	info:eu-repo/semantics/acceptedVersion